Document is current
Any future updates will be listed below
-
Authors
Rechtman, Or Genzer
Slae, Mordechai https://orcid.org/0000-0001-8309-0045
-
Funding
Funding for this research was provided by:
Hebrew University of Jerusalem
- License Information
-
More Information
Article History
Received: 15 September 2025
Accepted: 5 December 2025
First Online: 20 December 2025
Declarations
:
: Or Genzer Rechtman has no conflicts of interest or financial ties to disclose. Dr Mordechai Slae has the following relationships, none is related to the present paper —Talk fees, advisory board: Sanofi, Alexion, Neopharm-Israel, Rafa-Israel. Research—drug trials: Celgen, Takeda, Intercept, Astrazeneca, Nestle, Jansen, Elli Lilly, Alexion. Travel grants: Sanofi, Neopharm-Israel, Rafa-Israel.
